(Q33772712)

English

The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alzheimer's disease

0 references

0 references

0 references

pathophysiology

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Friedman JI

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Adler DN

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Davis KL

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1243-1252

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Impaired Learning and Decreased Cortical Norepinephrine after Bilateral Locus Coeruleus Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Brain Norepinephrine and Dopamine in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Number of neurons in nucleus locus ceruleus in demented and non-demented patients: rapid estimation and correlated parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Beta-adrenergic activation and memory for emotional events

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Serotonin receptor changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cortical Synapses and Reinforcement: a Hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Activation of the noradrenergic system facilitates an attentional shift in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Memory access pathway: Role of adrenergic versus cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Pharmacological alleviation of cholinergic lesion induced memory deficits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Animal models of Alzheimer's disease: behavior, pharmacology, transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Increased activity of surviving locus ceruleus neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Brain catecholamines modifications. The effects on memory facilitation induced by oxotremorine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Amygdala beta-noradrenergic influence on hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

The basomedial and basolateral amygdaloid nuclei contribute to the induction of long-term potentiation in the dentate gyrus in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Neocortical cholinergic innervation: A description of extrinsic and intrinsic components in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Adrenergic receptors in aging and Alzheimer's disease: Decreased α2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Schizophrenia: elevated cerebrospinal fluid norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

The noradrenergic system in Alzheimer and multi-infarct dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Noradrenaline and spatial memory

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Possible behavioural function for noradrenaline–acetylcholine interaction in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Oral physostigmine treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Development and plasticity of the locus coeruleus: a review of recent physiological and pharmacological experimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Postmortem studies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Some evidence for the involvement of adrenergic sites in the memory trace

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Neurotransmitters and CNS disease. Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Memory enhancement by central administration of norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Clonidine treatment of schizophrenia: can we predict treatment response?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Theories of the dorsal bundle extinction effect

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900232-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(99)00232-2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33772712&oldid=1633648633"